CODX vs PSA
Co-Diagnostics, Inc. Common Stock (CODX) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
PSA (PSA) common stock.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CODX currently screens at market cap $31.4M. PSA currently screens at market cap $0.
Not investment advice. Open the CODX and PSA stock pages for the full models.
Not investment advice.